Liquidia (LQDA) Research & Development (2020 - 2026)

Liquidia (LQDA) recorded quarterly Research & Development of $12.6 million in Q1 2026, down 25.8% quarter-over-quarter from $16.9 million in Q4 2025, and up 80.46% on a YoY basis from $7.0 million in Q1 2025.

Liquidia (LQDA) Research & Development (2020 - 2026) Analysis & Trends

Liquidia's Research & Development history runs 7 years deep, the most recent figure standing at $12.6 million for Q1 2026.

  • In Q1 2026, Research & Development rose 80.46% year-over-year to $12.6 million; the TTM figure through Mar 2026 stood at $44.9 million (changed 0.29% YoY), while the FY2025 annual figure was $39.3 million, down 17.9% from the prior year.
  • Research & Development was $12.6 million for Q1 2026 at Liquidia, down from $16.9 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $17.7 million in Q2 2023 to a low of $4.5 million in Q3 2022.
  • Historically, Research & Development has averaged $9.6 million across 5 years, with a median of $9.3 million in 2025.
  • The sharpest annual moves came in 2023 and 2024: Research & Development soared 239.05% in 2023, then sank 46.76% in 2024.
  • A 5-year view of Research & Development shows it stood at $5.0 million in 2022, then soared by 157.82% to $12.8 million in 2023, then gained by 28.42% to $16.5 million in 2024, then gained by 2.84% to $16.9 million in 2025, then retreated by 25.8% to $12.6 million in 2026.
  • The last three Research & Development figures came in at $12.6 million (Q1 2026), $16.9 million (Q4 2025), and $9.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 222.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 180.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 138.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 934,363.43
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 296.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 97.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 103.35 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 46.94 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 39.38 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn 12.57 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.57 Mn
Dec 31, 2025 16.94 Mn
Sep 30, 2025 9.35 Mn
Jun 30, 2025 6.02 Mn
Mar 31, 2025 6.97 Mn
Dec 31, 2024 16.48 Mn
Sep 30, 2024 11.89 Mn
Jun 30, 2024 9.42 Mn
Mar 31, 2024 10.06 Mn
Dec 31, 2023 12.83 Mn
Sep 30, 2023 7.44 Mn
Jun 30, 2023 17.70 Mn
Mar 31, 2023 5.28 Mn
Dec 31, 2022 4.98 Mn
Sep 30, 2022 4.51 Mn
Jun 30, 2022 5.22 Mn
Mar 31, 2022 4.73 Mn
Dec 31, 2021 5.38 Mn
Sep 30, 2021 4.49 Mn
Jun 30, 2021 4.60 Mn